Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 63.55 HKD 4.44% Market Closed
Market Cap: 23.7B HKD

Wall Street
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 105.75 HKD with a low forecast of 91.61 HKD and a high forecast of 119.7 HKD.

Lowest
Price Target
91.61 HKD
44% Upside
Average
Price Target
105.75 HKD
66% Upside
Highest
Price Target
119.7 HKD
88% Upside
Ascentage Pharma Group International Competitors:
Price Targets
0HS8
Caladrius Biosciences Inc
526% Upside
ORKA
Oruka Therapeutics Inc
55% Upside
INSM
Insmed Inc
7% Upside
PEB
Pacific Edge Ltd
20% Downside
PGEN
Precigen Inc
141% Upside
LENZ
Graphite Bio Inc
101% Upside
EQ
Equillium Inc
199% Upside
GNFT
Genfit SA
90% Upside

Revenue
Forecast

Revenue Estimate
Ascentage Pharma Group International

For the last 7 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 106%. The projected CAGR for the next 3 years is 24%.

106%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascentage Pharma Group International's stock price target?
Price Target
105.75 HKD

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 105.75 HKD with a low forecast of 91.61 HKD and a high forecast of 119.7 HKD.

What is Ascentage Pharma Group International's Revenue forecast?
Projected CAGR
24%

For the last 7 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 106%. The projected CAGR for the next 3 years is 24%.

Back to Top